Johnson & Johnson is acquiring full ownership of Verb Surgical, buying out the share held by Alphabet’s Verily Life Sciences LLC, after a four-year collaboration to develop a digital surgery platform.
J&J announced on 20 December its plans to acquire the remaining stake from Verily and move the robotic surgery platform to market alone
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?